File size: 6,526 Bytes
a6a5d8e
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
# Vertical Governance Policy: Pharmaceutical — 21 CFR Part 11 / FDA AI/ML Action Plan
# Doctrine v6 | R3 Adversarial Receipts
# Last revised: 2025-07

schema_version: "1.0.0"
vertical: pharmaceutical
regime: 21-CFR-Part-11/FDA-AI-ML
effective_date: "2025-07-01"
jurisdiction: US-FDA

meta:
  title: "Pharmaceutical AI Governance Policy — 21 CFR Part 11 / FDA AI/ML Alignment"
  description: >
    Maps FDA 21 CFR Part 11 Electronic Records/Signatures, FDA AI/ML-Based SaMD
    Action Plan, and ICH E6(R3) GCP to Doctrine v6 Λ-axes for AI systems used
    in drug discovery, clinical trials, and regulatory submissions.
  authority: "21 CFR Part 11; 21 CFR Part 820 (QSR); FDA AI/ML Action Plan (Jan 2021); ICH E6(R3) (2023); ICH Q10"
  receipt_chain_required: true
  merkle_root_algorithm: SHA3-256
  gxp_category: GCP/GMP/GLP

regulatory_clauses:
  - clause_id: CFR11-11.10a
    title: "Closed Systems — Validation"
    citation: "21 CFR § 11.10(a)"
    full_ref: "21 C.F.R. § 11.10(a) — Validation of systems to ensure accuracy, reliability, consistent intended performance"
    lambda_axes:
      - axis: Λ8
        label: Robustness
        weight: 1.0
        enforcement: mandatory
        rationale: >
          AI/ML systems used in GxP contexts must be validated per ISPE GAMP 5
          Category 5; validation protocol and results hashed into receipt chain.
      - axis: Λ7
        label: Auditability
        weight: 0.95
        enforcement: mandatory

  - clause_id: CFR11-11.10e
    title: "Audit Trails — Sequence of Events"
    citation: "21 CFR § 11.10(e)"
    full_ref: "21 C.F.R. § 11.10(e) — Use of secure, computer-generated, time-stamped audit trails"
    lambda_axes:
      - axis: Λ7
        label: Auditability
        weight: 1.0
        enforcement: mandatory
        rationale: >
          Tamper-evident audit trail for all AI-generated records; Merkle DAG
          satisfies "secure, time-stamped" requirement with TAI64N timestamps.
      - axis: Λ6
        label: Security
        weight: 0.90
        enforcement: mandatory

  - clause_id: CFR11-11.50
    title: "Signature Manifestations"
    citation: "21 CFR § 11.50"
    full_ref: "21 C.F.R. § 11.50 — Signed electronic records must contain the printed name, date/time, meaning of signature"
    lambda_axes:
      - axis: Λ2
        label: Accountability
        weight: 1.0
        enforcement: mandatory
        rationale: >
          AI-generated regulatory submissions must carry qualified electronic
          signatures (QES per eIDAS or 21 CFR Part 11); signature metadata
          embedded in receipt chain leaf node.
      - axis: Λ1
        label: Transparency
        weight: 0.88
        enforcement: mandatory

  - clause_id: FDA-AIML-SAMD-PREDETERMINED
    title: "Predetermined Change Control Plan for AI/ML SaMD"
    citation: "FDA Draft Guidance — Predetermined Change Control Plan for AI/ML-Based SaMD (Apr 2023)"
    full_ref: "FDA Draft Guidance: Marketing Submission Recommendations for AI/ML-Based SaMD (2023 Apr)"
    lambda_axes:
      - axis: Λ8
        label: Robustness
        weight: 0.92
        enforcement: mandatory
        rationale: >
          Each model update under a PCCP must be documented with performance
          comparator receipts (pre/post-update metrics, distribution shift scores).
      - axis: Λ9
        label: Explainability
        weight: 0.85
        enforcement: mandatory

  - clause_id: ICH-E6R3-5.5
    title: "GCP — Sponsor's Responsibilities: Trial Management"
    citation: "ICH E6(R3) § 5.5 (2023)"
    full_ref: "ICH E6(R3) Integrated Addendum § 5.5 — Sponsor responsibilities for trial management systems"
    lambda_axes:
      - axis: Λ2
        label: Accountability
        weight: 0.88
        enforcement: mandatory
        rationale: >
          Sponsor is accountable for AI-assisted randomization, EDC, and
          statistical analysis; each algorithm run hashed into trial receipt chain.
      - axis: Λ4
        label: Fairness
        weight: 0.80
        enforcement: mandatory
        rationale: >
          Clinical trial AI must not introduce bias in patient stratification;
          demographic parity receipts required for adaptive trial designs.

  - clause_id: CFR820-QSR-820.30
    title: "Design Controls"
    citation: "21 CFR § 820.30"
    full_ref: "21 C.F.R. § 820.30 — Design and development controls for device software including AI/ML"
    lambda_axes:
      - axis: Λ5
        label: Safety
        weight: 0.92
        enforcement: mandatory
      - axis: Λ1
        label: Transparency
        weight: 0.80
        enforcement: mandatory
        rationale: >
          Design history file (DHF) must include AI model architecture,
          training data specifications, and risk management per ISO 14971.

  - clause_id: ICH-Q10-APQR
    title: "Annual Product Quality Review — AI-Assisted Manufacturing"
    citation: "ICH Q10 § 2.3; 21 CFR § 211.180(e)"
    full_ref: "ICH Q10 § 2.3 — Annual product quality review; 21 C.F.R. § 211.180(e)"
    lambda_axes:
      - axis: Λ3
        label: Privacy
        weight: 0.72
        enforcement: recommended
        rationale: >
          Patient-level data used in AI-assisted batch release must be
          pseudonymised; access receipts log data subject category.
      - axis: Λ7
        label: Auditability
        weight: 0.90
        enforcement: mandatory

  - clause_id: EU-AI-ACT-CLASS3
    title: "EU AI Act — High-Risk Classification: Medical Devices"
    citation: "EU AI Act Art. 6(2); Annex III § 5(a) (2024/1689)"
    full_ref: "Regulation (EU) 2024/1689 Art. 6(2) — High-risk AI system classification; Annex III § 5(a) medical devices"
    lambda_axes:
      - axis: Λ1
        label: Transparency
        weight: 0.90
        enforcement: mandatory
        rationale: >
          High-risk AI systems must register in EU AI Act database; receipt
          chain provides registration evidence with EU notified body signature.
      - axis: Λ10
        label: Sovereignty
        weight: 0.82
        enforcement: mandatory

compliance_thresholds:
  minimum_lambda_coverage: 7
  mandatory_axes: [Λ2, Λ7, Λ8]
  receipt_retention_days: 5475        # 15 years GCP/GMP
  max_samd_inference_latency_ms: 300
  gxp_validation_cycle_days: 365

receipt_chain:
  algorithm: SHA3-256
  chaining: merkle_dag
  quorum: 2-of-3
  nodes: [primary, gxp-backup, regulatory-archive]
  qualified_electronic_signature: true